Sharma, Abhinav <br/><br/>
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.  [electronic resource] 

 -  Journal of the American Heart Association  01 2020 
 - e012797 p.  digital 
<br/><br/> Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.119.012797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--blood<br/>Aged<br/>Biomarkers--blood<br/>Blood Proteins<br/>Diabetes Mellitus, Type 2--blood<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Galectin 3--blood<br/>Galectins<br/>Growth Differentiation Factor 15--blood<br/>Heart Disease Risk Factors<br/>Heart Failure--etiology<br/>Hospitalization<br/>Humans<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Piperidines--therapeutic use<br/>Prognosis<br/>Risk Assessment<br/>Troponin I--blood<br/>Uracil--analogs & derivatives